The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(benzyloxy)-N-(furan-2-ylmethyl)benzamide ID: ALA4582169
PubChem CID: 4946386
Max Phase: Preclinical
Molecular Formula: C19H17NO3
Molecular Weight: 307.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccco1)c1ccccc1OCc1ccccc1
Standard InChI: InChI=1S/C19H17NO3/c21-19(20-13-16-9-6-12-22-16)17-10-4-5-11-18(17)23-14-15-7-2-1-3-8-15/h1-12H,13-14H2,(H,20,21)
Standard InChI Key: HNMKHUDNWMUETF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
27.2177 -2.6290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2165 -3.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9246 -3.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6342 -3.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6314 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9228 -2.2201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3376 -2.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0468 -2.6201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3345 -1.3970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7530 -2.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4606 -2.6181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3426 -3.8556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3438 -4.6727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0522 -5.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0489 -5.8948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7564 -6.3022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4644 -5.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4605 -5.0710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7524 -4.6673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5467 -3.4279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3462 -3.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7556 -2.8908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2090 -2.2829 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
11 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 11 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1208AlogP: 3.79#Rotatable Bonds: 6Polar Surface Area: 51.47Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.90CX Basic pKa: ┄CX LogP: 3.40CX LogD: 3.40Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.45
References 1. Li Y, Huang T, Lou B, Ye D, Qi X, Li X, Hu S, Ding T, Chen Y, Cao Y, Mo M, Dong J, Wei M, Chu Y, Li H, Jiang XC, Cheng N, Zhou L.. (2019) Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor., 163 [PMID:30580239 ] [10.1016/j.ejmech.2018.12.028 ]